Increase/Decrease in Cash: The total change in cash for the company over the given period.
Boundless Bio, Inc. (BOLD) had Increase/Decrease in Cash of $2.88M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-65.36M |
|
-- |
|
-- |
|
$73.27M |
|
$-73.27M |
|
$7.90M |
|
$-65.36M |
|
$-65.36M |
|
$-65.36M |
|
$-65.36M |
|
$-65.36M |
|
$-65.36M |
|
$-73.27M |
|
$-72.18M |
|
16.98M |
|
16.98M |
|
$-3.85 |
|
$-3.85 |
|
| Balance Sheet Financials | |
$154.39M |
|
$4.32M |
|
$52.02M |
|
$206.41M |
|
$8.13M |
|
$47.63M |
|
$47.63M |
|
$55.77M |
|
$150.64M |
|
$150.64M |
|
$150.64M |
|
22.30M |
|
| Cash Flow Statement Financials | |
$-60.84M |
|
$-26.10M |
|
$89.82M |
|
$24.27M |
|
$27.15M |
|
|
Increase/Decrease in Cash |
$2.88M |
$7.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.98 |
|
-- |
|
-- |
|
0.24 |
|
0.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-63.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.39% |
|
-43.39% |
|
-31.67% |
|
-32.97% |
|
$6.76 |
|
$-3.73 |
|
$-3.58 |
|